> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Warning Letter Sent to CBD Marketer Over Covid Claims
- URL: https://www.fdaweb.com/warning-letter-sent-to-cbd-marketer-over-covid-claims/
- Published: 2020-10-23T12:00:00.000Z
- Updated: 2026-09-14T16:33:48.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147946

FDA has sent For Our Vets (Mesa, AZ) a [Warning Letter](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/our-vets-llc-dba-patriot-supreme-611043-10162020?ref=fdaweb.com) after reviewing its Web site and social media sites and determined that it offers cannabinoid (CBD) products for sale that are intended to mitigate, prevent, treat, diagnose, or cure Covid-19, making them unapproved drugs. FDA said it was bothered by marketing claims the company was making. In one claim, the company said: “CBD May Play a Role in Helping Lung Symptoms. Cannabis contains several cannabinoids that have anti-inflammatory properties. Specifically, CBD is the most likely possibility for treating Covid-19 related lung inflammation.” The agency told the company to take immediate action to cease the sale of such unapproved and unauthorized products.